How Medicines Are Made: Understanding the 4 Phases of Clinical Trials

Most of us are at least somewhat familiar with psychiatric medications, like antidepressants or anxiety treatments. Few people know how these medications are created and actually reach the public. Every medication on the market has gone through years of careful research and development before it becomes available to treat any condition. At the heart of this development process are clinical trials, which are essential to determining whether a particular treatment is safe and effective.

Research and development occur in phases to ensure each treatment is studied carefully and safely. At Excell Research, we conduct clinical trials across the development spectrum. Before these phases begin, there’s also an important early step: preclinical research.

Before Trials Begin: Preclinical Research

Before a treatment is ever tested on people, it goes through years of laboratory research. Researchers test to see how the treatment works, how it might affect the body, and whether it shows enough promise to move into clinical trials. This process is essential in ensuring basic safety.

Phase 1: Is It Safe?

If early results are promising, the treatment is then moved into Phase 1 trials. Here, the treatment is tested on a small group of participants. The purpose of this stage is to determine a safe dosage amount and identify potential side effects. In this phase, it’s all about safety and monitoring how the body responds to the treatment.

Phase 2: Does It Work?

After a successful Phase 1, the treatment moves to Phase 2, where it is tested on a larger group of people who have the condition the drug is designed to treat. In this Phase, researchers determine how well the treatment works, the side effects, and whether it should continue being developed.

At Excell Research, we help evaluate the effectiveness of new treatments for mental health conditions and monitor how participants respond in real-world settings.

Phase 3: Is It Better Than Current Options?

In Phase 3, the treatment is tested on an even larger, more diverse group to compare against standard treatments or against a placebo. Researchers determine the treatment’s overall effectiveness and safety. Excell Research also plays a key role in this phase, helping to ensure that only safe and effective treatment options move forward.

Phase 4: What Happens After Approval?

If the treatment is FDA-approved and made available to the public, it’s then moved into Phase 4. This stage is known as post-marketing surveillance. During Phase 4, researchers continue to monitor the treatment’s long-term effectiveness, rare side effects, and how it performs in different populations over time. Phase 4 helps ensure the treatment remains safe and effective for the wider public.

How Excell Research Moves Health Care Forward

Each phase is a crucial stage in which new treatments are tested in real-world settings to determine their effectiveness and how they compare to existing options. At Excell Research, we conduct trials across all phases with a current focus on Phases 2 and 3. The results of these trials help decide whether a treatment should progress and eventually become available to the public. By participating in a trial, you are contributing to the future of mental health care. Interested in joining a clinical trial? Click here to learn more.

Want to learn more about clinical trial phases and how treatments are developed? Visit the FDA’s Drug Development Process Overview and the World Health Organization’s clinical trials page for more information.